胃癌,淋巴结送检数目,腹腔镜手术,影响因素," /> 胃癌,淋巴结送检数目,腹腔镜手术,影响因素,"/> ,Laparoscopic surgery,Influencing factor,"/> <span style="font-family:宋体;">进展期胃癌患者腹腔镜根治术最佳淋巴结送检数目的</span><span style="font-family:宋体;font-size:12px;">影响因素分析</span>

临床肿瘤学杂志 ›› 2022, Vol. 27 ›› Issue (03): 227-231.

• • 上一篇    下一篇

进展期胃癌患者腹腔镜根治术最佳淋巴结送检数目的影响因素分析

  

  1. 1  453003  河南新乡  新乡医学院研究生院 450003  河南省人民医院肿瘤科 3 450003   河南省人民医院临床单细胞生物医学中心
  • 收稿日期:2020-10-29 修回日期:2022-11-04 出版日期:2022-03-25 发布日期:2022-05-12

Influencing factors of optimal number of lymph node detection in laparoscopic radical gastrectomy for advanced gastric cancer

  1. Graduate School of Xinxiang Medical University, Xinxiang 453003,China
  • Received:2020-10-29 Revised:2022-11-04 Online:2022-03-25 Published:2022-05-12

摘要:  

目的 探讨影响腹腔镜进展期胃癌根治术切除标本中最佳淋巴结送检数目的相关影响因素。方法 回顾性分析20181月至20207月行腹腔镜胃癌根治手术的536例进展期胃癌患者的临床病理资料,记录术后淋巴结送检数目,统计分析各因素对淋巴结送检数目的影响。结果 536例患者中,无淋巴结转移147例,有淋巴结转移389例。无淋巴结转移患者中,淋巴结送检数目≥16枚组与淋巴结送检数目<16枚组间肿瘤直径的差异有统计学意义(P=0.027);受试者工作特征(ROC)曲线分析显示,肿瘤直径预测淋巴结送检数目≥16枚的曲线下面积为0.71995%CI0.6270.810P<0.001),最佳截断值为2.8 cm。有淋巴结转移患者中,淋巴结送检数目≥30枚组与淋巴结送检数目<30枚组间年龄和淋巴结转移的差异有统计学意义(P<0.05);多因素Logistic回归分析显示,年龄和淋巴结转移(N3aN3b)均为影响淋巴结送检数目<30枚的独立因素(P0.05);ROC曲线分析显示,年龄、淋巴结转移预测淋巴结送检数目≥30枚的曲线下面积分别为0.57595%CI0.5190.632P=0.008)和0.61595%CI0.5590.672P0.001),最佳截断值分别为54岁和6枚。结论 肿瘤直径≤2.8 cm的无淋巴结转移患者术后淋巴结送检数目更有可能<16枚;年龄>54岁、淋巴结转移数目≤6枚的有淋巴结转移患者术后淋巴结送检数目更有可能<30枚。在临床工作中需综合考虑各影响因素,保证充足的淋巴结送检数目。

关键词: font-size:10.5pt, 胃癌')">">胃癌, 淋巴结送检数目, 腹腔镜手术, 影响因素

Abstract:  

Objective To analyze the factors influencing the optimal number of lymph node detection in laparoscopic radical gastrectomy for advanced gastric cancer. Methods The data of 536 patients with advanced gastric cancer who underwent laparoscopic radical gastrectomy from January 2018 to July 2020 were reviewed, and the clinicopathological data was analyzed. The number of lymph nodes was submitted for detection after surgery, and the factors influencing the number of lymph nodes for detection were analyzed. Results Among the 536 patients, 147 had no lymph node metastasis and 389 had lymph node metastasis. In patients without lymph node metastasis, there was a statistically significant difference in tumor diameter between the group with lymph node number 16 and the group with lymph node number <16 (P=0.027). Receiver operator characteristic (ROC) curve analysis showed that the area under curve of the tumor diameter predicting the number of lymph nodes 16 for detection was 0.719 (95% CI:0.627-0.810, P<0.001), and the optimal cut'off value was 2.8 cm. In patients with lymph node metastasis, there were statistically significant differences in age and lymph node metastasis between the group with lymph node number 30 and the group with lymph node number<30 (P<0.05). The results of multivariate Logistic regression analysis showed that age and lymph node metastasis (N3a and N3b)were independent factors affecting lymph nodes number <30 for detection(P< 0.05). ROC curve analysis showed that the area under curve of age and lymph node metastasis predicting number of lymph node metastasis30 for detection were 0.575 (95% CI:0.519-0.632, P=0.008) and 0.615 (95% CI:0.559-0.672,P<0.001), respectively. The optimal cut'off values were 54 years old and 6. Conclusion Patients with tumor diameter 2.8 cm without lymph node metastasis were more likely to have <16 lymph nodes for detection. Patients aged >54 years and with no more than 6 metastatic lymph nodes were more likely to have <30 lymph nodes for detection. In clinical work, various influencing factors should be comprehensively considered to ensure sufficient lymph node detection, so as to formulate individualized treatment plan and improve the quality of treatment.

Key words: Gastric tumor, Number of lymph nodes detection')">">, Laparoscopic surgery')">">, Influencing factor

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 许景艳1,欧阳建,章宜芬2,周荣富1,陈 兵1,张启国1,杨永公1,邵小雁1,徐 勇1,关朝阳1. 原发性肋骨血管肉瘤的诊治探讨[J]. 临床肿瘤学杂志, 2009, 14(1): 70 .
[2] 徐晓明1,唐金海1,刘万花2,郑凯尔2,秦建伟1,赵祥生1,张 彤3. 触诊阴性乳腺癌的定位方法与同期手术治疗[J]. 临床肿瘤学杂志, 2009, 14(1): 43 .
[3] 战怀兵,蔡曦光,吴凤铭. Bmi-1和hTERT在非小细胞肺癌中的表达及相关性研究[J]. 临床肿瘤学杂志, 2009, 14(1): 10 .
[4] 朱 芳,李振宇,任精华,伍 钢,彭 纲. VEGF与肿瘤血管生成拟态关系的研究[J]. 临床肿瘤学杂志, 2009, 14(1): 20 .
[5] 黄培钰1,汪 波2,张 星3,洪明晃1,吴 烜4,陈明远1,张 力1,4. 组织芯片技术分析c-kit蛋白在鼻咽癌组织中的表达及其临床意义[J]. 临床肿瘤学杂志, 2009, 14(2): 97 .
[6] 王 轩,陆 雷,华长江,江 涛,李增才,张 斌,刘现忠,许正昌. 原位肝移植治疗原发性肝癌68例报告[J]. 临床肿瘤学杂志, 2009, 14(2): 147 .
[7] 周 晔1,冯 虹1. 促血管生成素1、2及Tie2受体mRNA在卵巢上皮性浆液性腺癌中的表达[J]. 临床肿瘤学杂志, 2009, 14(2): 144 .
[8] 吴俚蓉,胡春宏. DNA错配修复基因hMLH1与肿瘤及化疗耐药相关性的研究进展[J]. 临床肿瘤学杂志, 2009, 14(3): 274 .
[9] 孙来荣1,顾连兵1,沈宗丽2,朱月清2,钱燕宁3. 老年食管癌患者围术期T淋巴细胞亚群的变化[J]. 临床肿瘤学杂志, 2009, 14(3): 225 .
[10] 蔡铭泉1,陈 强2,施纯枚2 . 受体三阴性乳腺癌的研究进展[J]. 临床肿瘤学杂志, 2009, 14(3): 283 .